Information provided through this questionnaire will be used by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Regulatory Innovation Office (RIO) to support regulatory learning, policy development, and the design of a potential AI for Medicines Safety sandbox. Responses will be handled in accordance with UK data protection law (UK GDPR and the Data Protection Act 2018), stored securely, and accessed only by authorised MHRA and RIO staff. Analysis will focus on aggregated themes and insights; any outputs shared beyond the project team will be anonymised and de-identified, with no organisation specific information published or shared without consent. Responses will not be used for regulatory enforcement or compliance assessment, and personal data will be retained only for as long as necessary to support this work and any agreed follow up engagement.
Questions in this survey should be answered with reference to the AI project(s) within your own remit and do not need to reflect all AI related activity across your organisation.